Emergence of oseltamivir-resistant pandemic (H1N1) 2009 virus within 48 hours. - Wikidata - wikimedia - TriplyDB

Emergence of oseltamivir-resistant pandemic (H1N1) 2009 virus within 48 hours.

Emergence of oseltamivir-resistant pandemic (H1N1) 2009 virus within 48 hours.

http://www.wikidata.org/entity/Q30394187

about

Clinical Implications of Antiviral Resistance in Influenza Discovery of Influenza A Virus Sequence Pairs and Their Combinations for Simultaneous Heterosubtypic Targeting that Hedge against Antiviral Resistance Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance Prospective surveillance and molecular characterization of seasonal influenza in a university cohort in Singapore How bioinformatics influences health informatics: usage of biomolecular sequences, expression profiles and automated microscopic image analyses for clinical needs and public health Two years after pandemic influenza A/2009/H1N1: what have we learned?Pandemic influenza: a never-ending story.Monitoring and characterization of oseltamivir-resistant pandemic (H1N1) 2009 virus, Japan, 2009-2010.Changing epidemiology of respiratory viral infections in hematopoietic cell transplant recipients and solid organ transplant recipients.Triple-combination antiviral drug for pandemic H1N1 influenza virus infection in critically ill patients on mechanical ventilation.Influenza outbreaks in Singapore: epidemiology, diagnosis, treatment and prevention.Systematic identification of H274Y compensatory mutations in influenza A virus neuraminidase by high-throughput screening.Insight into the oseltamivir resistance R292K mutation in H5N1 influenza virus: a molecular docking and molecular dynamics approach.Cryptoporus volvatus extract inhibits influenza virus replication in vitro and in vivo Field monitoring of avian influenza viruses: whole-genome sequencing and tracking of neuraminidase evolution using 454 pyrosequencing.Identification of small molecule inhibitors for influenza a virus using in silico and in vitro approaches.Deep sequencing: becoming a critical tool in clinical virology.Epidemiology of viral respiratory tract infections in an outpatient haematology facility.The inhibitory performance of flavonoid cyanidin-3-sambubiocide against H274Y mutation in H1N1 influenza virus.Combined aerosolized Toll-like receptor ligands are an effective therapeutic agent against influenza pneumonia when co-administered with oseltamivir.

P2860

Q26782746-1D4CE706-36E7-4826-B977-F578E9B07E81 Q27316994-B078DDD1-BAFB-4B6E-88F2-5D0D7A0B3134 Q28282405-0FC57F09-52A5-457D-B3B0-0A1AB9D334CA Q28539676-FF2F0D95-9153-4766-A0AE-0EA567177A46 Q28649612-C8D79259-2270-4D38-A247-13DFE771A920 Q30224656-ECCB0F34-5574-4C02-8A47-6E63633AB349 Q30353560-D442F776-A42A-4CB4-927D-F492167A4649 Q30400621-15CFDCB3-17E1-4ACB-8AF1-DB2B5D102815 Q30403699-F5B63B48-4C6E-4678-801A-FEBB6980B66C Q30407719-E7687E5B-E934-48C6-A0BA-0A3AD6FF1703 Q30420892-24B011E4-B906-4A51-AB19-C56BD0D3DBA1 Q30423620-B4813C06-BD37-4B45-BB91-B253FFFA2A0E Q30432293-5307815D-9B9B-4D6B-B705-B8DDDB681207 Q34600066-799F53F6-70D5-40CE-891E-8BE7340025EF Q36172253-6D0AB475-4AB7-4B6F-99D1-1C4A5EE58AE5 Q36300881-EEDB7532-7ED8-4196-9EE0-6DF2AC91D595 Q38226696-6C49DC0D-2DEC-416B-945E-B376696AB947 Q42245439-35805C2D-677C-4127-B53B-9AC1422D58BD Q45323867-EE019331-45B1-43F6-A417-FE01CB832ACB Q47601706-10F90A32-F279-4742-99FF-F72A9FD92E79

P2860

Emergence of oseltamivir-resistant pandemic (H1N1) 2009 virus within 48 hours.

http://www.wikidata.org/entity/Q30394187

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Emergence of oseltamivir-resistant pandemic (H1N1) 2009 virus within 48 hours.

@ast

Emergence of oseltamivir-resistant pandemic (H1N1) 2009 virus within 48 hours.

@en

type

label

Emergence of oseltamivir-resistant pandemic (H1N1) 2009 virus within 48 hours.

@ast

Emergence of oseltamivir-resistant pandemic (H1N1) 2009 virus within 48 hours.

@en

prefLabel

Emergence of oseltamivir-resistant pandemic (H1N1) 2009 virus within 48 hours.

@ast

Emergence of oseltamivir-resistant pandemic (H1N1) 2009 virus within 48 hours.

@en

P1433

Q30394187-7AFE4DEF-9552-472C-88DA-56E1E243CECA

P1476

Q30394187-EC798548-C734-41A3-BF8A-1B0C5AE80CF7

P2093

Q30394187-02D6D77D-3790-4EDB-AAB0-CE616F149617

Q30394187-39124F86-28C0-422E-A69A-A03D6A753C0D

Q30394187-4B7DF923-AD5E-49C5-AD6B-6C5CF9B88F2B

Q30394187-9EAB2543-B6B5-4EE2-A331-D13EF0F0BE47

Q30394187-D3371ECD-0C97-472E-A20D-00DC81DA0B7C

Q30394187-E146241B-A283-4891-B992-BA98CFD43044

Q30394187-FF46298D-1669-4A6E-BBCB-4AAD89CFF69C

P2860

Q30394187-1B1D5AEB-8CE3-4DA3-AC7F-8DDE2760131D

Q30394187-21C7A78B-8440-41A9-9E13-8FF59775C850

Q30394187-257EAB92-B5F1-483F-9CAB-386B12014D15

Q30394187-33873708-17BA-4F90-9AFD-7E3D6541DD4F

Q30394187-4155C107-BB88-4287-ABBC-3ADFA24D250B

Q30394187-6867EDED-239C-44F9-8BE9-95C43654ACF1

Q30394187-6F1FC703-ADD3-457A-9385-5C9636AE15F2

Q30394187-743EE668-F9A4-4289-9D4B-D4ED22E22D34

Q30394187-81768793-1414-4F57-8140-DD5A1DA69BEC

Q30394187-8E51C63D-F9FC-4B06-AA45-475701B7C347

P304

Q30394187-F264E33B-1D2E-402C-9322-0B10D05E4CD9

P31

Q30394187-4FCD0A5D-6283-485C-9F89-FE7B2A6706EB

Q30394187-b9750204-8142-461c-aaa4-80c8aa56001f

P356

Q30394187-097D9A12-D390-4D45-AD8A-42C3A152C326

P433

Q30394187-42499353-346D-4D4C-9D7F-C17FDCACA6CD

P478

Q30394187-9148E5B1-8DDA-4CCF-AA2F-F4E70D1693F5

P50

Q30394187-35CCDE89-3912-4323-A271-2767E851987D

Q30394187-CC36DC3C-3D61-42F6-BF93-E151EE27079E

Q30394187-F0CABDCB-42AF-4059-B7A5-329E842155A1

P577

Q30394187-BEF358F8-EDEF-4058-9065-BBBBE939A1DB

P5875

Q30394187-42E355BF-6641-4A85-BB60-6A561CBDA35B

P698

Q30394187-31D0F945-65DF-466C-9D4B-50256537F652

P921

Q30394187-5FFE5F36-FF13-4571-8732-D82FBEE07F08

P932

Q30394187-87427D2E-B281-4B7F-896C-6C1D8F05A079

P356

P1433

Emerging Infectious Diseases

P1476

Emergence of oseltamivir-resistant pandemic (H1N1) 2009 virus within 48 hours.

@en

P2093

Christopher W Wong

http://www.w3.org/2001/XMLSchema#string

Cui Lin

http://www.w3.org/2001/XMLSchema#string

Kwai Peng Chan

http://www.w3.org/2001/XMLSchema#string

Masafumi Inoue

http://www.w3.org/2001/XMLSchema#string

Raphael Tze Chuen Lee

http://www.w3.org/2001/XMLSchema#string

Raymond Lin

http://www.w3.org/2001/XMLSchema#string

Timothy Barkham

http://www.w3.org/2001/XMLSchema#string

P2860

Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis

Critically Ill patients with 2009 influenza A(H1N1) in Mexico

Use of oseltamivir in 12 European countries between 2002 and 2007--lack of association with the appearance of oseltamivir-resistant influenza A(H1N1) viruses.

Oseltamivir-induced resistant pandemic A/H1N1 influenza virus in a child with cystic fibrosis and Pseudomonas aeruginosa infection.

Rapid selection of oseltamivir- and peramivir-resistant pandemic H1N1 virus during therapy in 2 immunocompromised hosts

Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia.

Influenza virus resistance to antiviral agents: a plea for rational use.

Permissive secondary mutations enable the evolution of influenza oseltamivir resistance.

Global transmission of oseltamivir-resistant influenza.

Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada.

P304

1633-1636

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3201/EID1610.100688

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Sebastian Maurer-Stroh

P577

2010-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46577498

http://www.w3.org/2001/XMLSchema#string

P698

20875299

http://www.w3.org/2001/XMLSchema#string

P921

P932

3294403

http://www.w3.org/2001/XMLSchema#string